Tables
TABLE 1 REGULATORY SCENARIO 17
TABLE 2 GLOBAL COMPANION DIAGNOSTICS MARKET REVENUE BY REGIONS' 2017-2024 ($MILLION) 38
TABLE 3 GLOBAL COMPANION DIAGNOSTICS MARKET BY VENDOR RANKING' 2017 48
TABLE 4 OTHER PROMINENT VENDORS OF COMPANION DIAGNOSTICS MARKET 49
TABLE 5 F. HOFFMANN-LA ROCHE: OFFERINGS 50
TABLE 6 F. HOFFMANN-LA ROCHE: RECENT DEVELOPMENTS 51
TABLE 7 QIAGEN N.V.: PRODUCT OFFERINGS 58
TABLE 8 QIAGEN N.V.: RECENT DEVELOPMENTS 58
TABLE 9 ABBOTT LABORATORIES: PRODUCT OFFERINGS 65
TABLE 10 ABBOTT LABORATORIES: RECENT DEVELOPMENTS 65
TABLE 11 MYRIAD GENETICS: PRODUCT DESCRIPTION 72
TABLE 12 MYRIAD GENETICS: RECENT DEVELOPMENTS 72
TABLE 13 AGILENT TECHNOLOGIES INC.: PRODUCT OFFERINGS 78
TABLE 14 AGILENT TECHNOLOGIES INC.: RECENT DEVELOPMENTS 79
TABLE 15 BIOMERIEUX S.A.: SNAPSHOT 86
TABLE 16 DANAHER CORPORATION: SNAPSHOT 87
TABLE 17 RESONANCE HEALTH LIMITED: SNAPSHOT 89
TABLE 18 THERMO FISHER SCIENTIFIC: SNAPSHOT 91
TABLE 19 GENOMIC HEALTH: SNAPSHOT 94
LIST OF FIGURE
Charts
CHART 1 RESEARCH METHODOLOGY OF GLOBAL COMPANION DIAGNOSTICS MARKET 12
CHART 2 GLOBAL COMPANION DIAGNOSTICS MARKET REVENUE' 2017-2024 ($MILLION) 15
CHART 3 PEST ANALYSIS OF GLOBAL COMPANION DIAGNOSTICS MARKET 18
CHART 4 PORTER 5 FORCES ON GLOBAL COMPANION DIAGNOSTICS MARKET 20
CHART 5 DRO - IMPACT ANALYSIS OF GLOBAL COMPANION DIAGNOSTICS MARKET 25
CHART 6 KEY STAKEHOLDERS 26
CHART 7 GLOBAL COMPANION DIAGNOSTICS MARKET BY TECHNOLOGY SEGMENTATION' 2017 (%) 27
CHART 8 GLOBAL COMPANION DIAGNOSTICS MARKET BY APPLICATION SEGMENTATION' 2017 (%) 31
CHART 9 GLOBAL COMPANION DIAGNOSTIC MARKET BY CANCER APPLICATION SEGMENTATION' 2017 (%) 32
CHART 10 GLOBAL COMPANION DIAGNOSTICS MARKET BY END-USERS SEGMENTATION' 2017 (%) 36
CHART 11 GLOBAL COMPANION DIAGNOSTICS MARKET BY GEOGRAPHICAL SEGMENTATION' 2017 (%) 38
CHART 12 COMPANION DIAGNOSTICS MARKET REVENUE IN NORTH AMERICA' 2017-2024 ($MILLION) 39
CHART 13 COMPANION DIAGNOSTICS MARKET REVENUE IN EUROPE' 2017-2024 ($MILLION) 41
CHART 14 COMPANION DIAGNOSTICS REVENUE IN ASIA-PACIFIC' 2017-2024 ($MILLION) 43
CHART 15 COMPANION DIAGNOSTICS MARKET REVENUE IN REST OF THE WORLD' 2017-2024 ($MILLION) 45
CHART 20 QIAGEN N.V.: OVERVIEW SNAPSHOT 61
CHART 21 QIAGEN N.V.: GEOGRAPHICAL PRESENCE 62
CHART 22 QIAGEN N.V.: SWOT ANALYSIS 63
CHART 23 ABBOTT LABORATORIES: OVERVIEW SNAPSHOT 67
CHART 24 ABBOTT LABORATORIES.: BUSINESS UNITS 68
CHART 25 ABBOTT LABORATORIES: GEOGRAPHIC PRESENCE 68
CHART 26 ABBOTT LABORATORIES.: SWOT ANALYSIS 70
CHART 27 MYRIAD GENETICS: OVERVIEW SNAPSHOT 73
CHART 28 MYRIAD GENETICS: BUSINESS UNITS 74
CHART 29 MYRIAD GENETICS: SWOT ANALYSIS 76
CHART 30 AGILENT TECHNOLOGIES INC.: OVERVIEW SNAPSHOT 80
CHART 31 AGILENT TECHNOLOGIES INC.: BUSINESS UNITS 81
CHART 32 AGILENT TECHNOLOGIES: GEOGRAPHICAL PRESENCE 82
CHART 33 AGILENT TECHNOLOGIES INC.: SWOT ANALYSIS 83